Clinical Trial Update: A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating JNJ-86974680 in participants with advanced non-small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• JNJ-86974680

Snippet

Sponsor: Johnson & Johnson Enterprise Innovation Inc. | Conditions: Carcinoma, Non-small-Cell Lung | Phase 1 | Status: RECRUITING